Moderna's mRNA Flu Shot Outperforms Standard Vaccine by 27%

A groundbreaking trial shows Moderna's new mRNA flu vaccine is 27% more effective than traditional flu shots, offering hope for better protection during flu season.

The technology's faster production could mean vaccines that better match circulating strains.